DocDollars

Paragon 28, Inc.

CO · United States · Reporting entity ID 100000010964

Total reported 2019–2025
$53.2M
#167 of 2,960 reporting companies — 0.1% of all reported industry payments
$45.1M in general payments across 28,438 records, plus $1.31M in research funding across 228 records.

How it breaks down

General payments $45,077,133
Research funding $1,309,468
Ownership & investment $6,853,762

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Paragon 28, Inc. reported $53.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #167 of 2,960 reporting companies. 2% of that was research funding and 98% general payments such as consulting, speaking, food and travel. 28,438 general payment records and 228 research records were filed.

Common questions about Paragon 28, Inc.

How much has Paragon 28, Inc. paid US doctors?

Paragon 28, Inc. reported $53,240,362 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $45,077,133 in general payments, $1,309,468 in research funding and $6,853,762 in ownership and investment interests.

How does Paragon 28, Inc. rank among drug and device companies?

It ranks #167 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Paragon 28, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.